XBiotech Inc. (XBIT)
NASDAQ: XBIT · Real-Time Price · USD
2.305
-0.055 (-2.33%)
Jul 9, 2026, 2:46 PM EDT - Market open
XBiotech Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 115.46 | 125.55 | 172.68 | 200.02 | 157.31 | 236.98 |
Short-Term Investments | - | - | - | - | 60.17 | - |
Cash & Short-Term Investments | 115.46 | 125.55 | 172.68 | 200.02 | 217.48 | 236.98 |
Cash Growth | -25.94% | -27.29% | -13.67% | -8.03% | -8.23% | -0.16% |
Other Receivables | 0.3 | 0.36 | 0.86 | 0.94 | 1.76 | 8.95 |
Total Trade Receivables | 0.3 | 0.36 | 0.86 | 0.94 | 1.76 | 8.95 |
Other Current Assets | 1.29 | 1.04 | 1.03 | 0.76 | 0.6 | 0.93 |
Total Current Assets | 117.05 | 126.95 | 174.57 | 201.72 | 219.84 | 246.87 |
Net Property, Plant & Equipment | 22.79 | 23.13 | 24.53 | 24.9 | 26.26 | 28.31 |
Total Assets | 139.84 | 150.08 | 199.09 | 226.62 | 246.1 | 275.18 |
Accounts Payable | 0.86 | 1.54 | 2.22 | 2.52 | 2.41 | 2.07 |
Accrued Expenses | 2.04 | 6.32 | 2.63 | 3.5 | 1.6 | 1.37 |
Short-Term Debt | - | - | 10.25 | - | - | - |
Other Current Liabilities | 0.11 | 0.08 | - | 0.08 | 0.06 | 0.01 |
Total Current Liabilities | 3 | 7.93 | 15.11 | 6.1 | 4.07 | 3.45 |
Other Long-Term Liabilities | 1.82 | 1.8 | 1.72 | 1.67 | 1.64 | 2.34 |
Total Long-Term Liabilities | 1.82 | 1.8 | 1.72 | 1.67 | 1.64 | 2.34 |
Total Liabilities | 4.82 | 9.73 | 16.83 | 7.77 | 5.7 | 5.79 |
Common Stock | 276.9 | 276.73 | 273.11 | 271.15 | 267.33 | 262.26 |
Accumulated Other Comprehensive Income | - | - | - | - | 0.83 | 1.97 |
Retained Earnings | -141.88 | -136.38 | -90.84 | -52.31 | -27.75 | 5.15 |
Shareholders' Equity | 135.02 | 140.35 | 182.27 | 218.85 | 240.4 | 269.39 |
Total Liabilities & Equity | 139.84 | 150.08 | 199.09 | 226.62 | 246.1 | 275.18 |
Total Debt | - | 0 | 10.25 | 0 | 0 | 0 |
Net Cash (Debt) | 115.46 | 125.55 | 162.43 | 200.02 | 217.48 | 236.98 |
Net Cash Growth | -8.04% | -22.70% | -18.80% | -8.03% | -8.23% | -0.16% |
Net Cash Per Share | 3.79 | 4.12 | 5.33 | 6.57 | 5.72 | 7.89 |
Book Value | 135.02 | 140.35 | 182.27 | 218.85 | 240.4 | 269.39 |
Book Value Per Share | 4.43 | 4.60 | 5.98 | 7.19 | 6.33 | 8.97 |
Tangible Book Value | 135.02 | 140.35 | 182.27 | 218.85 | 240.4 | 269.39 |
Tangible Book Value Per Share | 4.43 | 4.60 | 5.98 | 7.19 | 6.33 | 8.97 |